Citizen Petition from American College of Obstetricians and Gynecologists
Details
The document's own metadata, straight from the source system.
- Title
- Citizen Petition from American College of Obstetricians and Gynecologists
- Posted
- Feb 4, 2025
- Comment period
- Feb 4, 2025 – ?
- Topics
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Stance breakdown
Who commented
Breakdown by commenter type.
Comments over time
Weekly arrivals, stacked by stance.
Support × commenter type
How each type splits across stance.
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Uncheck an issue to choose another.
| Organization | Environmental impact of mifepristone | Informed consent and side effects | Mifepristone access and ipv | Mifepristone safety and efficacy | Rems requirements |
|---|
12 organization-typed comments could not be identified.
Explorer
Every mirrored comment — filter by stance, campaign, or issue.
- Aug 13, 2025Comment from Lynn PisanielloSupportIndividual
A physician who has delivered over a thousand babies supports the petition's goal of restricting the medication to prescription-only status. They argue that the medication should only be prescribed by physicians with specific hospital privileges to manage potential complications.
Read comment → - Aug 3, 2025Comment from Braden RichmondOpposeIndividual
A board-certified OB/GYN and member of ACOG opposes the citizen petition. The commenter argues that the current unsupervised use of mifepristone is a political rather than scientific decision and urges the FDA to reinstate pre-2016 REMS requirements.
Read comment → - Jul 28, 2025Comment from Nick StephanoffOpposeIndividual
The commenter argues that managing pregnancy with medication requires the involvement of a physician and expresses skepticism about the scientific basis of the proposal. They specifically criticize the American College of Obstetricians and Gynecologists (ACOG) for being a political rather than a scientific organization.
Read comment → - Jul 22, 2025Comment from AnonymousOpposeAdvocacy
The American College of Obstetricians and Gynecologists opposes the current FDA regulations regarding mifepristone, arguing that the drug's real-world adverse event rate is significantly higher than previously reported. They call for the FDA to reinstate original safeguards, including mandatory in-person physician examinations, prescription requirements, and strict follow-up protocols.
Read comment →
